GNFT news: 07:30 AM EDT, 05/03/2021 (MT Newswires) -- Genfit (GNFT) said Monday its partner Labcorp (LH) has launched NASHnext, a non-invasive test for nonalcoholic steatohepatitis, in the US and Canada. In September 2020, Genfit entered into a licensing agreement with Labcorp for the development and commercialization of a blood-based molecular diagnostic test powered by Genfit's technology. Genfit shares were up nearly 6% in premarket trading, while Labcorp was flat. Price: 4.5500, Change: +0.25, Percent Change: +5.81 http://www.mtnewswires.com Copyright © 2021 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.